ShareSoc Webinar with Arecor Therapeutics plc (AREC)
07 March 2023

Company: Arecor Therapeutics plc (AREC)
Date:
07 March 2023
Time: 4pm
Format: Webinar
Presenters: Sarah Howell Ph.D (Chief Executive Officer) and Susan Lowther (Chief Financial Officer)

Company Information: Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying its innovative proprietary formulation technology platform, Arestat™, Arecor are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver enhanced formulations of their therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio.

Presenters bios:

Sarah Howell was appointed Chief Executive Officer of Arecor in 2015, having joined in 2011 as Chief Operating Officer and Executive Director. During her time at Arecor she has led the transformation of the business into a successful clinical stage biotechnology company. Sarah has a background in clinical and commercial pharmaceutical product development, manufacture, supply, and licensing across a range of product types and therapeutic areas.

She has served in a number of senior roles in the pharmaceutical industry, including Vice President CMC & Technical Development at BTG Plc., and Director of Outsourced Manufacturing at UCB-Celltech. Sarah holds a BSc in Chemistry from the University of Birmingham and a Ph.D. in Physical Organic Chemistry from the University of St Andrews.

Susan Lowther was appointed Chief Financial Officer and Company Secretary at Arecor in 2019. She brings significant financial leadership experience across a broad range of public and private life science companies. Susan joined Arecor from IXICO plc, an imaging contract research organisation where she defined the financing strategy and raised growth capital taking the company on a path to profitability.

Previously, she was Chief Financial Officer at Novacyt S.A. where she oversaw the acquisition of Lab21 Limited, CFO at BioWisdom Limited, who were acquired by Instem Plc, and Finance Director of RiboTargets Limited, from start-up until its acquisition by Vernalis plc.

Susan’s life-sciences career started at Celltech Group plc and included Head of Finance at Lonza Biologics (previously Celltech Biologics). As part of the leadership team, she was responsible for finance, HR, IT and facilities functions in the US and UK. Susan has been a member of executive boards since 1997 and a Fellow of the Chartered Institute of Management Accountants since 2003.

Registration
If you are already a member of ShareSoc you must log in prior to registering, then just click “REGISTER” below. If you are not already a member of ShareSoc, please complete the form below to sign up as an Associate member and then click “REGISTER”.

Click here for help on logging in.

Once you have registered you will receive an email notification, as well as reminders 1 day and 1 hour before the event starts.

Register for Webinar

Add to calendar
Event Details:
  • Event: ShareSoc Webinar with Arecor Therapeutics plc (AREC) - 07 March 2023
  • Date: 07/03/2023
  • Time: Presentation Starts at 4pm
  • Location: Webinar
Add to calendar
Event Details:
  • Event ShareSoc Webinar with Arecor Therapeutics plc (AREC) - 07 March 2023
  • Date 07/03/2023
  • Time Presentation Starts at 4pm
  • Location Webinar
  • Description Presenter:
    Sarah Howell Ph.D (Chief Executive Officer)
    Susan Lowther (Chief Financial Officer)